Reliable Data You Can Trust
Reliable Data You Can Trust
A recent
report published by Infinium Global Research on the translational regenerative
medicine market provides an in-depth analysis of segments and sub-segments in the
global as well as regional translational regenerative medicine market. The
study also highlights the impact of drivers, restraints, and macro indicators
on the global and regional translational regenerative medicine market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecasts, and dollar values of the global translational regenerative
medicine market. According to the report, the global translational regenerative
medicine market is projected to grow at a CAGR of 11% over the forecast period
of 2022-2028.
The value of
the translational regenerative medicine market in 2022 was USD 3 billion and is
expected to reach USD 5 billion in 2028 and is expected be growing with a CAGR
of more than 11%. Regenerative medicine is a branch of translational research
in tissue engineering and molecular biology. Regenerative medicines deal with
the process of engineering & replacing human cells, tissues or organs to
restore or establish normal function. Regenerative medicines primarily help to
restore the structure and function of damaged tissues and organs by stimulating
the body’s own repair mechanism. These medicines are used in a wide range of
degenerative disorders such as dermatology, neurodegenerative diseases, and
cardiovascular and orthopedic applications. A huge number of proof-of-concept
experiments in regenerative medicine have been conducted over the last few
decades.
The covid-19
had a direct impact on the ongoing R&D activities of the translational
regenerative medicine market. Due to the adoption of stringent measures, the
number of research staff working on these R&D activities in various
institutions and R&D facilities declined which may have led to delays in
the R&D activities and cost overruns, and also a scarcity of crucial
components used in these R&D activities due to supply chain disruptions.
Though, the covid-19 pandemic has also presented new opportunities in the
market. As translational regenerative medicine market can be developed for
treating the covid-19 virus and also there have been some instances of
developing such medicine during the pandemic. Rising awareness among people
regarding regenerative medicines, increasing government initiatives across the
globe, and growing aging population & healthcare expenditure are considered
to be the key factors driving the growth of the global translational
regenerative medicine market. However, the higher cost of research and
development and complex government approval processes are major restraints for
the global translational regenerative medicine market. Growing investments in the R&D of
new regenerative medicines along with constant rise growth in the aging
population are expected to bring new opportunities for growth over the forecast
period.
Geographically,
North America is expected to be the dominating region in the market over the
forecast period. Asia-Pacific is expected to be the fastest-growing region in
the market. High medical reimbursement facilities and technological advancement
in the region are considered to be the key factors driving the dominance of
North America in the global translational regenerative medicines market. Furthermore, North
America has advanced research and development base with many independent
laboratories, and academic institutions conducting research on the
translational regenerative medicine market in collaboration with medicine
companies. Asia-Pacific is expected to be the fastest-growing region in the world
owing to the rapid growth of the healthcare industry in the region.
The report
on the global translational regenerative medicine market covers segments such
as product type and application. On the basis of product type, the sub-markets
include tissue engineered products, cell based products, and gene therapy
products. On the basis of application, the sub-markets include orthopedic,
dermatology, cardiovascular, neurology, oncology, diabetes, and others.
The report
provides profiles of the companies in the market such as Anika Therapeutics,
Nuvasive, Inc., Orthofix International N.V, Medipost, Athersys, Inc., Celgene
Corporation, Vericel Corporation, Novartis, Brainstorm Cell Therapeutics Inc.,
and Gamida Cell Ltd.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors driving and restraining this market's growth. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of the translational regenerative medicine
market. Moreover, the study highlights current market trends and provides
forecasts for 2022-2028. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.